Matches in Wikidata for { <http://www.wikidata.org/entity/Q37148218> ?p ?o ?g. }
- Q37148218 description "article científic" @default.
- Q37148218 description "article scientifique" @default.
- Q37148218 description "articolo scientifico" @default.
- Q37148218 description "artigo científico" @default.
- Q37148218 description "artículu científicu espublizáu en 2013" @default.
- Q37148218 description "bilimsel makale" @default.
- Q37148218 description "scientific article published on 08 August 2013" @default.
- Q37148218 description "vedecký článok" @default.
- Q37148218 description "vetenskaplig artikel" @default.
- Q37148218 description "videnskabelig artikel" @default.
- Q37148218 description "vědecký článek" @default.
- Q37148218 description "wetenschappelijk artikel" @default.
- Q37148218 description "wissenschaftlicher Artikel" @default.
- Q37148218 description "наукова стаття, опублікована в серпні 2013" @default.
- Q37148218 description "научни чланак" @default.
- Q37148218 description "مقالة علمية نشرت في 08 أغسطس 2013" @default.
- Q37148218 name "Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling" @default.
- Q37148218 name "Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling" @default.
- Q37148218 name "Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100" @default.
- Q37148218 type Item @default.
- Q37148218 label "Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling" @default.
- Q37148218 label "Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling" @default.
- Q37148218 label "Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100" @default.
- Q37148218 prefLabel "Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling" @default.
- Q37148218 prefLabel "Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling" @default.
- Q37148218 prefLabel "Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100" @default.
- Q37148218 P1433 Q37148218-B3710330-678D-48FF-8C7E-38AB1B6663A1 @default.
- Q37148218 P1476 Q37148218-6C48EBE9-D2A6-43A2-9EF4-07BADE739AFD @default.
- Q37148218 P2093 Q37148218-3CD16B4D-E941-43AA-A2AA-C7A0D3E0DC13 @default.
- Q37148218 P2093 Q37148218-3CE6A083-7DDE-48F6-9F47-8B8F25A2F544 @default.
- Q37148218 P2093 Q37148218-7D5845C7-9C71-4BBA-8B1E-FFAAB62957D5 @default.
- Q37148218 P2093 Q37148218-86A9C62F-E907-42FD-A63A-982F154F47A1 @default.
- Q37148218 P2093 Q37148218-EA0876CF-2323-47DF-8B62-F2D201C5A9DD @default.
- Q37148218 P2093 Q37148218-F70A8401-9F59-4CAF-9CEE-6F794AC8206F @default.
- Q37148218 P2860 Q37148218-026C5D31-E22A-40B2-9497-0E9C5C2A650C @default.
- Q37148218 P2860 Q37148218-044CA0C7-E2D6-4A14-B647-60CB0E06921E @default.
- Q37148218 P2860 Q37148218-0A7F362D-C451-4E7F-85CC-E67278A82868 @default.
- Q37148218 P2860 Q37148218-10225D71-A333-4BC9-AECA-22817AFA3FF2 @default.
- Q37148218 P2860 Q37148218-19DC4D9E-4E89-440D-9A63-551512E9ABC9 @default.
- Q37148218 P2860 Q37148218-1A8907AB-8801-4949-83D7-DCC889B9AD6B @default.
- Q37148218 P2860 Q37148218-3414EEC1-309A-4700-A94B-CFCB7FC92256 @default.
- Q37148218 P2860 Q37148218-3D854C01-F4D6-4520-BA98-CDA4F25DC522 @default.
- Q37148218 P2860 Q37148218-3FD650CF-DF77-46CD-A5A9-5D8B9FF507E3 @default.
- Q37148218 P2860 Q37148218-545CEA56-869D-45A8-8A75-CB34942B1347 @default.
- Q37148218 P2860 Q37148218-576A3142-835C-4BD1-A27A-93A5487FCBAA @default.
- Q37148218 P2860 Q37148218-58B5A3A0-C09D-4A52-A424-D5C67E54FBE1 @default.
- Q37148218 P2860 Q37148218-6B4F90F7-23FF-423F-B8CF-09686AE2A532 @default.
- Q37148218 P2860 Q37148218-70FA960B-020F-4B96-952D-7BBE4C111AD9 @default.
- Q37148218 P2860 Q37148218-7E9239B1-09F5-49D6-BDED-A274F1DA0C41 @default.
- Q37148218 P2860 Q37148218-85005D21-4A5D-4944-91E7-A6EFDC9E1A2E @default.
- Q37148218 P2860 Q37148218-85142B20-73D8-47A2-8B90-1DE352A12CD1 @default.
- Q37148218 P2860 Q37148218-A53AC336-BA9F-4014-8740-6EA81E0A222A @default.
- Q37148218 P2860 Q37148218-AB69E838-EE19-4D7D-9F9B-8322F1C0F0AD @default.
- Q37148218 P2860 Q37148218-ACD9D4E1-7A7D-400F-B474-C34A41C17837 @default.
- Q37148218 P2860 Q37148218-AD8DF573-095A-45E6-9BBF-F3067F3F7D5A @default.
- Q37148218 P2860 Q37148218-AE6A2777-DA71-4AB6-AA61-6BD61CD046E1 @default.
- Q37148218 P2860 Q37148218-AE70E938-F112-4FDF-89F4-8B36221F5449 @default.
- Q37148218 P2860 Q37148218-B08D5896-42A5-4093-BAAC-E0F958225E76 @default.
- Q37148218 P2860 Q37148218-B23A9526-8939-401D-97A0-2E8FB4C432C4 @default.
- Q37148218 P2860 Q37148218-BAE801E3-FC3B-422C-A2DB-F4A6CB8A872A @default.
- Q37148218 P2860 Q37148218-BE6A0E02-A7F7-41F4-914C-B6B75CA407F7 @default.
- Q37148218 P2860 Q37148218-C20B8491-A547-4FD3-BF18-B012C97E06B2 @default.
- Q37148218 P2860 Q37148218-C28D70DE-4C71-4C19-AF97-2CCAB45DCFEE @default.
- Q37148218 P2860 Q37148218-C7F6DECA-D3C5-4D7B-A243-D55C6A9516BC @default.
- Q37148218 P2860 Q37148218-C8A0F656-85A5-40DD-822C-9F3AEF63B434 @default.
- Q37148218 P2860 Q37148218-CCB51F62-02C8-4E1F-B26B-3657A38CEE00 @default.
- Q37148218 P2860 Q37148218-D8866C45-E3D4-409F-9DDD-BB6BB0CEEACB @default.
- Q37148218 P2860 Q37148218-DDE12625-D1DE-4BC2-9A0C-9D8BF30AB676 @default.
- Q37148218 P2860 Q37148218-E3DAFE4B-1274-45AC-931F-DE186A275056 @default.
- Q37148218 P2860 Q37148218-F5009327-D901-4030-8403-E2F8CD3F7349 @default.
- Q37148218 P2860 Q37148218-F8B78924-A56D-471B-BF9E-04F3A3D54B56 @default.
- Q37148218 P304 Q37148218-FE668EA6-7A2C-4861-81AB-BFCEB298A1F5 @default.
- Q37148218 P31 Q37148218-6910BC62-1ED6-4608-A2EC-1FD57AF095C6 @default.
- Q37148218 P356 Q37148218-63020A00-15F3-4982-8871-28C8572A59F1 @default.
- Q37148218 P407 Q37148218-03C3F601-B713-4BD3-A2C6-C08314DE54D8 @default.
- Q37148218 P4510 Q37148218-76ABEEE5-8D2F-4107-BFBA-0D18E68F5CCA @default.
- Q37148218 P478 Q37148218-51E951CD-0F52-4AD3-960C-989512316E2C @default.
- Q37148218 P577 Q37148218-36276B88-2053-4B72-A60B-A11BF7A86120 @default.
- Q37148218 P5875 Q37148218-E7E5BCA8-6E9E-412B-86D3-7207893BDC1D @default.
- Q37148218 P698 Q37148218-99D3419D-5103-4E9D-B237-644D6D096E3A @default.
- Q37148218 P921 Q37148218-04A1422A-E0C4-44F6-8BAE-EA6CB1036416 @default.
- Q37148218 P921 Q37148218-25B24EC9-2349-4622-AD0E-10C5ECAFFC25 @default.
- Q37148218 P921 Q37148218-8CBCFC0C-2004-4F73-B33B-D09F6C4AFDCB @default.
- Q37148218 P921 Q37148218-ECF1227D-6037-46A0-BF2C-950BBEAA11D6 @default.
- Q37148218 P932 Q37148218-2E3E5EF4-2011-4C67-831D-E7CA245D28CF @default.
- Q37148218 P356 CDDIS.2013.270 @default.
- Q37148218 P698 23928703 @default.
- Q37148218 P1433 Q2197222 @default.
- Q37148218 P1476 "Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling" @default.
- Q37148218 P2093 "C Chang" @default.
- Q37148218 P2093 "K Izumi" @default.
- Q37148218 P2093 "S O Lee" @default.
- Q37148218 P2093 "S Yeh" @default.
- Q37148218 P2093 "T-H Lin" @default.
- Q37148218 P2093 "W-J Lin" @default.
- Q37148218 P2860 Q24596926 @default.
- Q37148218 P2860 Q28143456 @default.
- Q37148218 P2860 Q28255665 @default.
- Q37148218 P2860 Q33955967 @default.
- Q37148218 P2860 Q34116435 @default.